|
|
||||||||
Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, North Carolina 27599-7248
| |
ABSTRACT |
|---|
|
|
|---|
Airways of Na+-K+-2Cl
(NKCC1)-deficient mice (
/
) were studied in Ussing chambers to
determine the role of the basolateral NKCC1 in transepithelial anion
secretion. The basal short-circuit current (Isc)
of tracheae and bronchi from adult mice did not differ between
NKCC1
/
and normal mice, whereas NKCC1
/
tracheae from neonatal
mice exhibited a significantly reduced basal
Isc. In normal mouse tracheae, sensitivity to
the NKCC1 inhibitor bumetanide correlated inversely with the age of the
mouse. In contrast, tracheae from NKCC1
/
mice at all ages were
insensitive to bumetanide. The anion secretory response to forskolin
did not differ between normal and NKCC1
/
tissues. However, when
larger anion secretory responses were induced with UTP, airways from
the NKCC1
/
mice exhibited an attenuated response. Ion substitution
and drug treatment protocols suggested that HCO
secretion in
NKCC1
/
airway epithelia. The absence of spontaneous airway disease
or pathology in airways from the NKCC1
/
mice suggests that the
NKCC1 mutant mice are able to compensate adequately for absence of the
NKCC1 protein.
bumetanide; Na+-K+-2Cl
cotransporter; bicarbonate secretion; chloride secretion
| |
INTRODUCTION |
|---|
|
|
|---|
IN ADDITION TO SODIUM
ABSORPTION, Cl
secretion and the osmotically linked
water flow across airway epithelia may contribute to the maintenance of
the depth of the airway surface liquid optimal for mucociliary
clearance. For Cl
secretion to be generated across the
epithelial cell, there must be coordination between apical
Cl
exit and basolateral Cl
entry as well as
maintenance of an electrochemical driving force to induce anion
secretion. The cAMP-mediated apical Cl
channel (cystic
fibrosis transmembrane conductance regulator; CFTR) has been
intensively investigated over the last 10 yr in an attempt to determine
how a defect in this channel causes airway disease in cystic fibrosis.
In addition, the Ca2+-activated apical Cl
channel has been extensively studied and is a potential therapeutic target through which Cl
can be secreted when CFTR is
absent/nonfunctional (2, 9, 29).
In contrast, much less attention has been directed at the basolateral
Cl
entry mechanisms. There are several Cl
transport mechanisms capable of moving Cl
across the
basolateral membrane and into the cell. However, it is generally
believed that the primary basolateral Cl
entry pathway in
airway epithelia is the
Na+-K+-2Cl
cotransporter (NKCC1)
(19). This transporter moves these ions electroneutrally
across the basolateral membrane, with the usual stoichiometry being 1 Na+:1 K+ and 2 Cl
(17). Bumetanide and other loop diuretics are effective at inhibiting NKCC1 (17) and thus have been used extensively
in investigating the physiology of this basolateral cotransport protein.
We have generated mice lacking functional NKCC1 (22) by gene targeting. Using a combination of ion substitution studies and bumetanide as well as other selected drugs, we have investigated the importance of NKCC1 in basal as well as stimulated anion secretory responses in freshly excised tracheae and bronchi from adult and neonatal mice.
| |
METHODS |
|---|
|
|
|---|
Using two targeting plasmids, we have generated two
NKCC1-deficient mouse lines in which the Slc12a2 gene, which
codes for NKCC1, was disrupted in embryonic stem cell lines.
One of the targeting plasmids,
Slc12a2
1065-1137, resulted in animals
carrying a deletion mutation, and the other plasmid,
Slc12a2
506-621, resulted in animals carrying
a null allele (22). Interestingly, the phenotype of the
animals carrying either of these mutations appears identical
(22). Animals carrying the null allele were used in this
investigation. Mice were bred on a heterogeneous strain background
(C57BL/6J+DBA/2J) (22).
Adult mice studied were 4-12 mo of age. The normal mice
(homozygous normal, +/+) had a mean body mass of 24.2 ± 0.66 g (n = 6), whereas the littermate NKCC1 mutant mice
(referred to as NKCC1
/
) had a significantly (P
0.01)
reduced body mass [18.l. ± 0.75 g (n = 5)] compared
with their normal littermates. (Not all animals used in this study were
weighed.) Animals were allowed access to food and water until they were
euthanized with 100% CO2.
The mouse pups studied remained with the mother until time of study.
The mean age of the pups studied was 10 days, excluding those used in
the study to correlate bumetanide sensitivity with age
(n = 28). The mean body mass of the normal
homozygous/heterozygous pups (5.67 ± 0.25g; n = 29) was significantly greater (P
0.01) than that of the
NKCC1
/
pups (3.9 ± 0.47 g; n = 15). The pups were
killed by decapitation. A piece of tail was obtained from each pup, and
genotype was determined by Southern blot (22) at a later
time. Thus these studies were done blinded with respect to genotype.
Details of the Ussing chamber setup have been previously published (14). Briefly, the adult tracheae were mounted on Ussing chambers having an exposed surface area of 0.025 cm2, whereas the bronchi (mainstem and occasionally secondary bronchi) and the neonatal tracheae were mounted on chambers with an exposed surface area of 0.014 cm2. All preparations were equilibrated for 30 min before the first bioelectric measurements were recorded. Electrical measurements were made under short-circuit conditions. Resistance was calculated by Ohm's law by measuring the short-circuit current (Isc) change in response to a constant voltage pulse (1 mV).
Solutions and drugs.
Unless otherwise stated, tissues were bathed bilaterally with
Krebs-Ringer bicarbonate (KRB) having the following composition (in
mM): 140 Na+, 120 Cl
, 5.2 K+, 1.2 Mg2+, 1.2 Ca2+, 2.4 HPO


-free HCO
buffer in the text), 115 mM sodium gluconate
replaced the NaCl and MgSO4 (1.2 mM) replaced the
MgCl2 [6 mM calcium gluconate was added to overcome the
Ca2+-chelating effects of gluconate, which replaced
CaCl2 (1.2 mM)]. For the Na+-free
buffer, N-methyl-D-glucamine (NMDG) replaced the
NaCl, and an NMDG HCO



4 M apical addition) was used to block
electrogenic Na+ absorption. Forskolin (10
5 M
apical) and UTP (10
4 M apical) were used to induce anion
secretion via an increase in cAMP and Ca
4 M), an
inhibitor of NKCC1, was added to the basolateral bath. DIDS
(10
3 M) was added to the basolateral bath to block the
Na+/HCO
/HCO
3 M bilaterally) was used to block the action of
carbonic anhydrase, the enzyme that catalyzes the endogenous production
of HCO
In situ hybridization. The probe preparation and in situ hybridizations were carried out as described previously (13).
Data calculation and statistics. All data are shown as means ± SE with the number of tissues indicated in parentheses. Data were compared by a Student's t-test if only two groups were being compared. If more than two groups were being compared, an analysis of variance and a Student-Newman-Keuls test were used for multiple comparisons among groups.
For the UTP data, both the peak UTP response and the mean UTP response were measured. The mean UTP response was the area of the UTP peak integrated (SigmaScan) over a 4-min period and was expressed as a current flux (nEq · cm
2 · 4 min
1).
| |
RESULTS |
|---|
|
|
|---|
Before physiological studies were performed, mRNA expression
studies of NKCC1 in the trachea and lung of the adult and neonatal mouse were carried out. Analysis of neonatal tracheal epithelia by in
situ hybridization revealed dense, homogeneous binding of NKCC1
antisense probe in the superficial epithelial layer (Fig. 1A). In contrast, in situ
hybridization analysis of NKCC1 mRNA expression in adult
tracheal epithelia revealed little or no tracheal expression of NKCC1
mRNA (Fig. 1C).
|
Adult tracheae.
In the trachea of the adult mouse, the basal
Isc, the amiloride-sensitive
Isc, and the residual Isc
(postamiloride) did not differ between the normal and the NKCC1
/
preparations (Fig. 2). The pattern of
response to drugs is shown in Fig. 3. The
only consistent difference between genotypes was that the UTP response in the normal preparations was more sustained (Fig. 3A) than
that exhibited by the NKCC1
/
tissues (Fig. 3B). The peak
changes in Isc in response to apical forskolin
or UTP did not differ between the genotypes (Fig. 3C).
However, when the UTP response was integrated over a 4-min period, the
NKCC1
/
tracheae exhibited significantly smaller "UTP mean
response" (expressed as a current flux) than did normal tissue (Fig.
3D, KRB). Interestingly, virtually none of the adult
tracheae (either normal or NKCC1
/
) exhibited a significant response
to bumetanide post-UTP (Fig. 3). Likewise, bumetanide did not decrease
the basal Isc or the response to forskolin when
given preforskolin (data not shown).
|
|
/
mice in an attempt to characterize the
ions required for the UTP-induced Isc. Data are
shown for mean UTP responses because this parameter was most
informative in discriminating between NKCC1
/
and normal tissue.
Removal of Cl
from the basolateral bath significantly
reduced the UTP mean response in the normal preparations but had no
effect on the mean UTP response in the NKCC1
/
preparations (Fig.
3D). In the basolateral Cl
-free buffer, the
magnitude of the mean UTP responses did not differ between the two genotypes.
Basolateral HCO

/
tissue compared with NKCC1
/
tissue in KRB (Fig. 3D). In
HCO
/
tissues
exhibited mean UTP responses that were reduced ~7.5-fold compared
with normal tissues in this buffer.
An additional group of tissue was studied in basolateral
Na+-free buffer. This protocol significantly reduced the
magnitude of the mean UTP response in the normal tissue compared with
the response in KRB. A similar pattern was seen for the NKCC1
/
tissue (Fig. 3D). In basolateral Na+-free
buffer, the
/
tissue exhibited a significantly attenuated mean UTP
response compared with the normal tissue incubated in the same buffer.
Adult bronchi.
The bronchi, like the tracheae, did not differ between genotypes with
respect to the basal Isc, amiloride-sensitive
Isc, or postamiloride Isc (Fig.
4A). The forskolin-stimulated
Isc also did not differ between the genotypes
(Fig. 4B). The peak UTP response did not differ
significantly between the genotypes (Fig. 4B), but again the
mean UTP response was significantly attenuated in the NKCC1
/
bronchi (Fig. 4C). The magnitude of the UTP response (mean
and peak) of the bronchi was significantly less (P
0.01) compared with the tracheal response for each respective genotype. In
contrast to the tracheae, the normal bronchi responded to bumetanide with a significant attenuation in the UTP-stimulated
Isc, whereas the NKCC1
/
bronchi failed to
respond to this drug (Fig. 4B).
|
Neonatal tracheae.
The trachea of neonatal mouse pups (mean age 10 days) was studied to
gain insight into the role of the basolateral NKCC1 in the
Cl
secretory response of the airway epithelium as a
function of age. Unlike in the adult trachea, the basal
Isc of the NKCC1
/
tissue was significantly
reduced compared with tissue from normal pups (Fig.
5A). The magnitude of the
amiloride-sensitive Isc was smaller in neonatal
than adult trachea but did not differ between the two genotypes. The
postamiloride Isc was significantly reduced in
the NKCC1
/
neonatal tracheae compared with normals (Fig. 5A). The response to forskolin was small and did not differ
between the two genotypes (Fig. 5B). However, the peak
response to UTP (Fig. 5B) as well as the mean UTP response
(see Fig. 7A, No Rx) was significantly attenuated in the
NKCC1
/
neonatal preparations (Fig. 5B). Interestingly,
unlike the normal adult tracheae, the normal neonatal tracheae
exhibited a significant response to bumetanide (post-UTP), whereas the
NKCC1
/
tissue failed to respond to the drug (Fig. 5B).
|
|
/
preparations (Fig.
7A). DIDS alone (basolateral)
failed to significantly alter the mean UTP response in either genotype
(Fig. 7A). A combination of DIDS and acetazolamide significantly reduced the mean UTP response in both genotypes (Fig.
7A). Indeed, in the NKCC1
/
tissue, a combination of both drugs abolished the mean UTP response. In contrast, in the normal preparations, the UTP response after addition of the two drugs remained
significantly greater than zero (Fig. 7A).
|
Isc
19.4 ± 3.1 µA · cm
2, n = 7), whereas this drug had no effect on the NKCC1
/
tissue. Pretreatment with bumetanide significantly decreased the mean UTP
response in the normal preparations (Fig. 7B) compared with No Rx (no treatment) normals (Fig. 7A). Furthermore, when
normal neonatal tracheae were treated with either bumetanide plus
acetzolamide or bumetanide plus DIDS (Fig. 7B), the UTP
response was significantly attenuated compared with the UTP response of
the untreated normal preparations (see Fig. 7A, No Rx).
In a final protocol, both normal and NKCC1
/
preparations were
treated with a combination of acetazolamide, DIDS, and bumetanide. This
protocol virtually eliminated the UTP mean response in both genotypes
(Fig. 7B). Bumetanide, as expected, did not have an additional effect on the NKCC1
/
tissue, and the response of NKCC1
/
preparations did not change significantly from the protocol in which acetazolamide and DIDS were given. When exposed to the three-drug combination, the mean UTP response did not differ
significantly between genotypes (Fig. 7B).
| |
DISCUSSION |
|---|
|
|
|---|
NKCC1 has been proposed as the principal basolateral
Cl
entry mechanism in airway epithelia (19).
This basolateral cotransporter, coupled with basolateral K+
channels, Na+-K+-ATPase, and apical
Cl
channels, has been suggested to work in concert to
effect Cl
secretion in many secretory epithelia
(17).
The loop diuretics (furosemide and bumetanide) bind to NKCC1 to inhibit
its function. The magnitude of bumetanide binding appears to reflect
the number of functional transport proteins in the basolateral membrane
(16). Thus we have used this drug as well as others
[acetazolamide (blocks endogenous HCO

/HCO
/
mice, we have obtained some insight into the role of NKCC1
in the basal and stimulated anion secretory response in murine airways.
In situ hybridization analyses revealed that the trachea of the
neonatal mouse expressed abundant mRNA encoding the cotransporter, while NKCC1 mRNA was not detected in the tracheae of adult mice (Fig.
1) (see also Ref. 24). In contrast to the adult tracheae, previous in situ studies revealed mRNA expression for NKCC1 in the
bronchi of adult mice (24). Our functional data
(bumetanide sensitivity) agreed with the in situ hybridization
data (Figs. 2, 4, and 5). We detected no bumetanide sensitivity
in the trachea of the normal adult mouse, whereas bumetanide was
effective in the neonatal tracheae and adult bronchi. Our data
demonstrated that bumetanide sensitivity in the trachea decreased with
age, and at ~6 wk of age the mouse trachea became refractory to loop diuretics (Fig. 6). However, it should be noted that we occasionally observed a bumetanide response in the tracheae of older mice (up to 6 mo). We and others have reported tracheal bumetanide (or furosemide)-sensitive Isc in mice older than 4 wk (14, 21, 27, 28). Consequently, there may be strain
differences in the age at which bumetanide sensitivity is lost, or
possibly some strains of mice do not lose tracheal bumetanide
sensitivity with age. Despite the absence of bumetanide sensitivity in
the normal adult tracheae, comparison of responses of wild-type and
NKCC1
/
mice indicated that NKCC1 was functional in adult tracheae
(see below). Thus these data point out that the lack of a response to
bumetanide cannot be used to conclude that there is no functional NKCC1.
Adult trachea.
The adult NKCC1
/
trachea exhibited no significant difference in the
basal Isc, amiloride-sensitive
Isc, or postamiloride Isc
compared with the pattern exhibited by trachea from the normal mouse
(Fig. 2). A substantial portion of the basal Isc
in the preparations of both genotypes was not amiloride sensitive and thus not likely due to Na+ absorption. We have previously
suggested that this "residual" (postamiloride)
Isc reflects anion secretion (14).
removal
(14, 28), this response was thought to predominantly reflect Cl
secretion. Because the forskolin response did
not differ between genotypes (Fig. 2C), it is likely that an
alternative means of basolateral anion entry, possibly
Cl
/HCO

/
trachea. Several isoforms of the AE have been cloned,
and in human airway tissue, mRNA for AE2 and AE3 have been molecularly
identified (11). In equine tracheal epithelium,
functional data suggest that in addition to NKCC1 entry,
Cl
enters the basolateral side via a
Cl
/HCO
/
mouse (12), which, using cultured tracheal cells
(presumably from adult mice), reported that the basal
Isc was significantly reduced in the NKCC1
/
tracheal cells compared with normal cells. Furthermore, the NKCC1
/
cells in that report failed to respond to amiloride. That study
(12) also reported a significantly attenuated forskolin
response in the NKCC1
/
cells. We have previously demonstrated
differences between cultured and freshly excised murine tracheae with
regard to ion transport properties (14). Thus it appears
that also, in this case, murine cultured airway epithelia do not
accurately reflect the ion transport properties of freshly excised tissue.
In our preparations, stimulation with UTP resulted in a much larger
increase in Isc than that observed after
forskolin stimulation (Fig. 3). Other studies have found that the
ATP-induced increase in Isc in the normal murine
tracheae likely reflects a major Cl
secretory component
(4, 5). Because UTP and ATP are equipotent for induction
of a secretory response in murine trachea (7), both
nucleotides likely act via the P2Y2 receptor to increase intracellular Ca2+. If the UTP response reflects
Cl
secretion and NKCC1 plays a role in basolateral
Cl
entry, then a difference in the UTP response between
the normal and NKCC1
/
tissue would be expected. Clearly, the UTP
response comprises at least two components, a fast, transient
"peak" and a slower, more sustained response. In our freshly
excised tracheal preparations, there was no difference in the magnitude
of the peak UTP response between genotypes. We integrated the UTP
response over a 4-min period (mean response) to quantitate the more
sustained phase of the UTP response. This mean response was
significantly reduced in the tracheae of the NKCC1
/
mice compared
with that in the tracheae of the normal mice. There are a number of
possibilities to explain the origin of the components of the UTP
response; one is that much of the peak response may be generated by the
secretion of intracellular Cl
(or
HCO
/
tracheae was more transient than in the control tissue (Fig. 3,
A and B). When this response was integrated over
a 4-min period, this mean response was significantly reduced in the
tracheae of NKCC1
/
mice compared with that in the tracheae of the
normal mice.
Although NKCC1 clearly plays a role in the UTP response, much of the
response is preserved in the NKCC1
/
mice. To determine which ions
were responsible for this response and basolateral entry mechanisms,
additional experiments were undertaken. In the NKCC1
/
trachea,
basolateral HCO
) removal
reduced the magnitude of the UTP response (Fig. 3D). Thus it
appears that ~60% of the UTP response in NKCC1
/
tissue was
dependent on the presence of basolateral HCO

secretion supported by
basolateral entry via an AE is less likely, due to the absence of an
effect of Cl
substitution on this response.
When Na+ was removed from the basolateral surface of the
tracheal preparations, the magnitude of the mean UTP response in the tracheae of both genotypes was significantly reduced compared with
respective preparations bathed in KRB (Fig. 3D). In the
NKCC1
/
tissues, the magnitude of the response in the
Na+-free media did not differ from that in basolateral
HCO
entry via NKCC1; 2) eliminating Cl
entry via
Cl
/HCO





/
tissue, the inhibition of the UTP response by
Na+ removal cannot reflect the first mechanism (cited
above). In addition, because basolateral Cl
removal did
not attenuate the magnitude of the UTP response, the second mechanism
appears to be unlikely. Therefore, the most likely scenario to explain
the attenuated UTP response in the NKCC1
/
tissue when bathed in
Na+-free media is that Na+ was necessary for
Na+/HCO
secretion but also a residual anion flux
(1), suggesting that airway epithelia may secrete
HCO



-free buffer, which was
suggested to also be HCO

channel
(6, 9, 20).
Adult bronchi.
The bioelectric properties of bronchi "missing" functional NKCC1
were very similar to those observed in the trachea. Only the mean UTP
response in the NKCC1
/
bronchi was significantly reduced compared
with controls. However, a major difference between the tracheae and the
bronchi was that the normal tracheae failed to respond to bumetanide,
whereas the normal bronchi exhibited a significant bumetanide response
(Fig. 4). None of the NKCC1
/
tissues, as expected, responded to
bumetanide. However, despite the molecular and functional evidence
(bumetanide sensitivity) that NKCC1 is more abundant in adult bronchi
and tracheae, both the peak and the mean UTP responses were
significantly smaller in bronchi compared with tracheae for each
genotype. Haas et al. (18) also reported that there was a
greater abundance of NKCC1 protein in bronchi compared with tracheae
(canine), yet in the canine bronchi the magnitude of the stimulated
Cl
secretory response was less (3, 15).
Boucher and Larsen (3) have suggested that there is a
larger basolateral Cl
conductance in canine bronchi than
in trachea; thus Cl
entering via NKCC1 would be shunted
across the basolateral membrane, blunting the Cl
secretory response. It is possible that in mice a similar scenario may
explain why the magnitude of anion secretory responses was less in the
murine bronchi compared with the tracheae.
Neonatal trachea.
To further characterize the importance of the NKCC1 cotransporter in
the Cl
secretory response of murine airway
epithelia, we investigated the basal and stimulated bioelectric
properties of neonatal trachea, which express abundant mRNA for the
cotransporter (Fig. 1) and a substantial response to bumetanide (Fig.
5). Unlike in the adult trachea, the basal and postamiloride
Isc were significantly reduced in the NKCC1
/
tracheae compared with normal neonatal tissue (Fig. 5). This finding
suggests that in normal neonatal tissue, NKCC1 is important for
supplying the Cl
to sustain the basal
Isc. The responses to forskolin were small and
did not differ between the two genotypes. However, in the neonatal
trachea, both the peak and the mean UTP responses were attenuated in
the NKCC1
/
tissue. Collectively, these data appear to reflect the
greater role of the cotransporter in normal neonatal tissue compared
with adult tissue.
/
tissue. Pretreatment of the tissues with DIDS
(basolateral) failed to alter the basal Isc of
the tracheae of either genotype (data not shown). Acetazolamide caused
a small but significant inhibition in the basal
Isc across the tracheae of both genotypes, but
the inhibition in the NKCC1
/
tissue (
Isc
9.8 ± 2.8 µA · cm
2, n = 6) was approximately double that in normal tissue
(
Isc
3.9 ± 0.8 µA · cm
2, n = 17). These data
indicate that endogenous HCO
/
tissue (Fig. 5),
and the magnitude of the postbumetanide UTP response did not differ
between the genotypes. Thus, as in normal adult airway, a significant
fraction of the UTP response (about one-third) did not appear to be
sustained by basolateral Cl
entry via NKCC1.
Acetazolamide significantly altered the magnitude of the UTP response
only in the NKCC1
/
tissue, and DIDS was without effect on the UTP
response of tissue of either genotype (Fig. 7A). However, pretreatment of the tissue with a combination of the two drugs significantly decreased the magnitude of the UTP response in both genotypes. In the normal tissue, this drug combination resulted in a
60% decrease in the magnitude of the UTP response, and in the
NKCC1
/
tissue, the UTP response did not differ significantly from
zero. The finding that, in combination, these drugs were additive
suggests that two separate processes were responsible for the UTP
secretory response. Unfortunately, the effect of DIDS is not specific,
and studies have shown that it can inhibit both the
Na+/HCO
/
tracheae (UTP response depends on basolateral Na+ and
HCO
) and the drug protocols
for the neonatal tracheae (total inhibition of the UTP response by
DIDS + acetazolamide), we speculate that the UTP response in the
NKCC1
/
tracheae was likely maintained by a basolateral
Na+/HCO

secretory component (data from the adult
normal trachea demonstrate that basolateral Cl
is
necessary; Fig. 3), with basolateral entry mediated via NKCC1. Therefore, the effect of bumetanide combined with either DIDS or
acetazolamide was tested on normal neonatal tissue (Fig.
7B). Both of these protocols significantly reduced the UTP
response in normal tissue to approximately the same extent (a reduction of ~75%). A combination of acetazolamide, DIDS, and bumetanide reduced the UTP response in the normal neonatal tissue to zero. Therefore, in normal neonatal trachea the basolateral entry pathways needed to maintain the UTP response appear to reflect a combination of
NKCC1, a DIDS-sensitive pathway (either
Na+/HCO

/
mouse exhibited a transport defect when a
vigorous anion secretory response was stimulated by UTP. Thus NKCC1
played a more dominant and rate-limiting role when the secretory
response was rapid and of relatively large magnitude. In contrast, when
the secretory response was of smaller magnitude (response to
forskolin), the responses in the NKCC1
/
tissues were not
attenuated, and the alternative basolateral anion entry mechanisms
appeared capable of sustaining secretion. Our data suggest that
secretion of HCO
/
airway epithelia were able to sustain (albeit reduced) a
secretory response to UTP. The absence of airway pathology in the
NKCC1
/
pups (12), along with the lack of spontaneous
airway disease in our older NKCC1
/
mice (unpublished observation),
add support to the hypothesis that the mice are able to compensate for
absence of the NKCC1 protein by other pathways.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Institutes of Health Grants SCOR I-P50 HL-60280-01 and PPG 5-POI-HL-34322 and Cystic Fibrosis Foundation RDP RO26 (Project 14).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: B. R. Grubb, Cystic Fibrosis/Pulmonary Research and Treatment Center, 7011 Thurston-Bowles Bldg., CB# 7248, Univ. of North Carolina, Chapel Hill, NC 27599-7248 (E-mail: bgrubb{at}med.unc.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 19 January 2001; accepted in final form 19 March 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Al-Bazzaz, FJ,
and
Al-Awqati Q.
Interaction between sodium and chloride transport in canine tracheal mucosa.
J Appl Physiol
46:
111-119,
1979
2.
Anderson, MP,
and
Welsh MJ.
Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia.
Proc Natl Acad Sci USA
88:
6003-6007,
1991
3.
Boucher, RC,
and
Larsen EH.
Comparison of ion transport by cultured secretory and absorptive canine airway epithelia.
Am J Physiol Cell Physiol
254:
C535-C547,
1988
4.
Clarke, LL,
Burns KA,
Bayle JY,
Boucher RC,
and
Van Scott MR.
Sodium and chloride conductive pathways in cultured mouse tracheal epithelium.
Am J Physiol Lung Cell Mol Physiol
263:
L519-L525,
1992
5.
Clarke, LL,
Grubb BR,
Gabriel SE,
Smithies O,
Koller BH,
and
Boucher RC.
Defective epithelial chloride transport in a gene targeted mouse model of cystic fibrosis.
Science
257:
1125-1128,
1992
6.
Clarke, LL,
Harline MC,
Gawenis LR,
Walker NM,
Turner JT,
and
Weisman GA.
Extracellular UTP stimulates electrogenic bicarbonate secretion across CFTR knockout gallbladder epithelium.
Am J Physiol Gastrointest Liver Physiol
279:
G132-G138,
2000
7.
Cressman, VL,
Lazarowski E,
Homolya L,
Boucher RC,
Koller BH,
and
Grubb BR.
Effect of loss of P2Y2 receptor gene expression on nucleotide regulation of murine epithelial Cl
transport.
J Biol Chem
274:
26461-26468,
1999
9.
Devor, DC,
Bridges RJ,
and
Pilewski JM.
Pharmacological modulation of ion transport across wild-type and
508 CFTR-expressing human bronchial epithelia.
Am J Physiol Cell Physiol
279:
C461-C479,
2000
10.
Devor, DC,
Singh AK,
Lambert LC,
DeLuca A,
Frizzell RA,
and
Bridges RJ.
Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells.
J Gen Physiol
113:
743-760,
1999
11.
Dudeja, PK,
Hafez N,
Tyagi S,
Gailey CA,
Toofanfard M,
Alrefai WA,
Nazir TM,
Ramaswamy K,
and
Al-Bazzaz FJ.
Expression of the Na+/H+ and Cl
/HCO
12.
Flagella, M,
Clarke LL,
Miller ML,
Erway LC,
Giannella RA,
Andringa A,
Gawenis LR,
Kramer J,
Duffy JJ,
Doetschman T,
Lorenz JN,
Yamoah EN,
Cardell EL,
and
Shull GE.
Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf.
J Biol Chem
274:
26946-26955,
1999
13.
Grubb, BR,
Lee E,
Pace AJ,
Koller BH,
and
Boucher RC.
Intestinal ion transport in NKCC1-deficient mice.
Am J Physiol Gastrointest Liver Physiol
279:
G707-G718,
2000
14.
Grubb, BR,
Paradiso AM,
and
Boucher RC.
Anomalies in ion transport in CF mouse tracheal epithelium.
Am J Physiol Cell Physiol
267:
C293-C300,
1994
15.
Grubb, BR,
Schiretz FR,
and
Boucher RC.
Volume transport across tracheal and bronchial airway epithelia in a tubular culture system.
Am J Physiol Cell Physiol
273:
C21-C29,
1997
16.
Haas, M.
The Na-K-Cl cotransporters.
Am J Physiol Cell Physiol
267:
C869-C885,
1994
17.
Haas, M,
and
Forbush B, III.
The Na-K-Cl cotransporter of secretory epithelia.
Annu Rev Physiol
62:
515-534,
2000[Web of Science][Medline].
18.
Haas, M,
Johnson LG,
and
Boucher RC.
Regulation of Na-K-Cl cotransport in cultured canine airway epithelia: a [3H]bumetanide binding study.
Am J Physiol Cell Physiol
259:
C557-C569,
1990
19.
Haas, M,
McBrayer DG,
and
Yankaskas JR.
Dual mechanisms for Na-K-Cl cotransport regulation in airway epithelial cells.
Am J Physiol Cell Physiol
264:
C189-C200,
1993
20.
Lee, MC,
Penland CM,
Widdicombe JH,
and
Wine JJ.
Evidence that Calu-3 human airway cells secrete bicarbonate.
Am J Physiol Lung Cell Mol Physiol
274:
L450-L453,
1998
21.
MacVinish, LJ,
Gill DR,
Hyde SC,
Mofford KA,
Evans MJ,
Higgins CF,
Colledge WH,
Huang L,
Sorgi F,
Ratcliff R,
and
Cuthbert AW.
Chloride secretion in the trachea of null cystic fibrosis mice: the effects of transfection with pTrial110-CFTR2.
J Physiol (Lond)
499:
677-687,
1997
22.
Pace, AJ,
Lee E,
Athirakul K,
Coffman TM,
O'Brien DA,
and
Koller BH.
Failure of spermatogenesis in mouse lines deficient in the Na+-K+-2Cl
cotransporter.
J Clin Invest
105:
441-450,
2000[Web of Science][Medline].
23.
Paradiso, AM,
and
Boucher RC.
Identification of basolateral Cl
/HCO
24.
Rochelle, LG,
Li DC,
Ye H,
Talbot CR,
and
Boucher RC.
Distribution of ion transport mRNAs throughout murine nose and lung.
Am J Physiol Lung Cell Mol Physiol
279:
L14-L24,
2000
25.
Romero, MF,
and
Boron WF.
Electrogenic Na+/HCO
26.
Smith, JJ,
and
Welsh MJ.
cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia.
J Clin Invest
89:
1148-1153,
1992.
27.
Smith, SN,
Alton EW,
and
Geddes DM.
Ion transport characteristics of the murine trachea and caecum.
Clin Sci (Colch)
82:
667-672,
1992[Medline].
28.
Smith, SN,
Steel DM,
Middleton PG,
Munkonge FM,
Geddes DM,
Caplen NJ,
Porteous DJ,
Dorin JR,
and
Alton EWFW
Bioelectric characteristics of exon 10 insertional cystic fibrosis mouse: comparison with humans.
Am J Physiol Cell Physiol
268:
C297-C307,
1995
29.
Stutts, MJ,
Chinet TC,
Mason SJ,
Fullton JM,
Clarke LL,
and
Boucher RC.
Regulation of chloride channels in normal and cystic fibrosis airway epithelial cells by extracellular ATP.
Proc Natl Acad Sci USA
89:
1621-1625,
1992
30.
Tessier, GJ,
Traynor TR,
Kannan MS,
and
O'Grady SM.
Mechanisms of sodium and chloride transport across equine tracheal epithelium.
Am J Physiol Lung Cell Mol Physiol
259:
L459-L467,
1990
31.
Welsh, MJ.
Inhibition of chloride secretion by furosemide in canine tracheal epithelium.
J Membr Biol
71:
219-226,
1983[Web of Science][Medline].
This article has been cited by other articles:
![]() |
M. Nguyen, A. J. Pace, and B. H. Koller Mice lacking NKCC1 are protected from development of bacteremia and hypothermic sepsis secondary to bacterial pneumonia J. Exp. Med., June 11, 2007; 204(6): 1383 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. McDaniel, A. J. Pace, S. Spiegel, R. Engelhardt, B. H. Koller, U. Seidler, and C. Lytle Role of Na-K-2Cl cotransporter-1 in gastric secretion of nonacidic fluid and pepsinogen Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G550 - G560. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gamba Molecular Physiology and Pathophysiology of Electroneutral Cation-Chloride Cotransporters Physiol Rev, April 1, 2005; 85(2): 423 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Sloan, B. R. Grubb, and S. Mager Expression of the amino acid transporter ATB0+ in lung: possible role in luminal protein removal Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L39 - L49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Meyer, M. Flagella, R. L. Sutliff, J. N. Lorenz, M. L. Nieman, C. S. Weber, R. J. Paul, and G. E. Shull Decreased blood pressure and vascular smooth muscle tone in mice lacking basolateral Na+-K+-2Cl- cotransporter Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1846 - H1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Grahammer, R. Warth, J. Barhanin, M. Bleich, and M. J. Hug The Small Conductance K+ Channel, KCNQ1. EXPRESSION, FUNCTION, AND SUBUNIT COMPOSITION IN MURINE TRACHEA J. Biol. Chem., November 2, 2001; 276(45): 42268 - 42275. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |